首页> 外国专利> Treatment of Melanoma with alpha Thymosin peptides in combination with an Activator of apoptosis, Heat Shock entineoplastico (hsaa)

Treatment of Melanoma with alpha Thymosin peptides in combination with an Activator of apoptosis, Heat Shock entineoplastico (hsaa)

机译:α胸腺肽与细胞凋亡激活剂,热休克性肠促性腺激素(hsaa)联合治疗黑色素瘤

摘要

The treatment of melanoma or melanoma metastasis in a human patient includes the treatment of melanoma and melanoma during the treatment It includes a combination of an alpha thymosin peptide and an anti-tumor thermal shock wave kinetics (Hsaa), such as sta-4783 (and alternative anti new plastic cytochemical agents, such as paclitaxel),And / or the option to add one or more antimissile agents. Item 3: method taken according to Item 1, in this treatment system, multi day treatment, this peptide Timothy alpha includes Timothy alpha 1 (TA1),TA1 is administered to the patient, with at least part of the dose in the range of about 0.5-10 mg / day.
机译:人类患者中黑色素瘤或黑色素瘤转移的治疗包括在治疗过程中黑色素瘤和黑色素瘤的治疗。它包括α胸腺素肽和抗肿瘤热冲击波动力学(Hsaa)的组合,例如sta-4783(和替代抗新型塑料细胞化学试剂,例如紫杉醇),和/或添加一种或多种反导剂的选择。第3项:根据第1项采取的方法,在该治疗系统的多日治疗中,该肽Timothy alpha包括Timothy alpha 1(TA1),TA1的给药剂量至少应在大约0.5-10毫克/天。

著录项

  • 公开/公告号AR069767A1

    专利类型

  • 公开/公告日2010-02-17

    原文格式PDF

  • 申请/专利权人 SCICLONE PHARMACEUTICALS INC;

    申请/专利号AR2008P105449

  • 发明设计人

    申请日2008-12-15

  • 分类号A61K38/00;A61K31/16;A61K31/337;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-21 18:47:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号